Table 2.
Complications after treatment of cesarean scar pregnancy.
| Complications (N = 10) |
No complications (N = 35) |
p value | |
|---|---|---|---|
| Gestational age (wks)∗ | 7.5 ± 1.43 | 7.69 ± 1.60 | 0.56 |
| Women age (y)∗ | 34.7 ± 2.71 | 33.4 ± 3.70 | 0.31 |
| previous CDs (no.)∗ | 2.70 ± 0.82 | 1.91 ± 0.92 | 0.019 |
| Myometrial thickness∗ (mm) | 1.94 ± 1.12 | 2.8 ± 0.97 | 0.018 |
| Rich vascular pattern§ | 9 (90) | 27 (77) | 0.37 |
| BhCG (mIU/mL)∗ | 35034 ± 52750 | 42434 ± 67085 | 0.75 |
| Treatment§ | ≤0.001 | ||
| EM | 1 (10) | 3 (8.6) | |
| HSC | 0 | 5 (14.3) | |
| MTX + D&S | 0 | 19 (54.3) | |
| UAE + D&S | 9 (90) | 2 (5.7) | |
| UAE + SURG | 0 | 6 (17.1) | |
| Risk Class§ | 0.03 | ||
| 1 | 6 (60.0) | 6 (17.1) | |
| 2 | 3 (30.0) | 21 (60.0) | |
| 3 | 1 (10.0) | 8 (22.9) |
EM: expectant management; HSC: hysteroscopic resection; MTH ii: methotrexate intramuscular injection; D&S: dilatation and suction; UAE: uterine artery embolization; Surg: surgery. ∗Data are shown as mean ± SD; statistical analysis performed by Student's t-test for unpaired data; §Data are shown as no. (percentage); statistical analysis performed by χ2 test.